Wunderlich Capital Managemnt’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-9,692
Closed -$1.63M 97
2018
Q1
$1.63M Buy
+9,692
New +$1.63M 1.12% 37
2017
Q4
Sell
-5,665
Closed -$1.16M 96
2017
Q3
$1.16M Buy
5,665
+4,182
+282% +$973K 0.87% 63
2017
Q2
$361K Sell
1,483
-40
-3% -$9.4K 0.27% 85
2017
Q1
$364K Buy
1,523
+300
+25% +$69.9K 0.28% 82
2016
Q4
$257K Buy
1,223
+466
+62% +$96.5K 0.21% 86
2016
Q3
$174K Buy
+757
New +$185K 0.14% 91
2015
Q4
Sell
-3,794
Closed -$1.03M 99
2015
Q3
$1.03M Buy
+3,794
New +$1.17M 0.95% 56

Other funds holding AGN

Wunderlich Capital Managemnt's AGN Position: Q2 2018 in Review

Wunderlich Capital Managemnt sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 9,692 shares — an estimated $1.63M sold.

Wunderlich Capital Managemnt first reported a position in AGN in Q3 2015 and held it in 7 quarters. The position peaked at $1.63M in Q1 2018. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Wunderlich Capital Managemnt reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Wunderlich Capital Managemnt sold 9,692 Allergan plc shares in Q2 2018, an estimated $1.63M.
  • Wunderlich Capital Managemnt first reported a position in Allergan plc in Q3 2015 and held it in 7 quarters.
  • Wunderlich Capital Managemnt's Allergan plc position peaked at $1.63M in Q1 2018.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Wunderlich Capital Managemnt's 13F filing for Q2 2018, filed 14 Aug 2018.